Medical device manufacturer C.R. Bard Inc. (NYSE: BCR) is buying health care products distributor Liberator Medical Holdings Inc. (NYSEMKT: LBMH) for $181 million, or $3.35 per share. The target closed at $2.66 on Nov. 10.
Liberator is a direct to consumer distributor of home medical supplies, such as catheters. The target estimates that the durable medical equipment, which makes treatment products that can be used repeatedly at home, is expected to grow from $45.8 billion in 2015 to $71.3 billion in 2023.